Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.
- Conditions
- Prostate Cancer
- Interventions
- Behavioral: Multimodal prehabilitation
- Registration Number
- NCT05553327
- Lead Sponsor
- Hospital Clinic of Barcelona
- Brief Summary
The aim of the study is to verify whether a multimodal prehabilitation programme prior to robotic radical prostatectomy contributes to a faster recovery of quality of life after surgery, to better functional results (including erectile function and continence) and to less perioperative anxiety.
- Detailed Description
Single center randomized clinical trial including prostate cancer patients undergoing robotic-assisted radical prostatectomy at the Hospital Clínic de Barcelona. Patients will be randomized into two groups, one receiving multimodal prehabilitation and the other a control group. Multimodal prehabilitation consists of improving the functional and mental capacity of an individual to cope with a significant stressor, in this case surgery. The design of our prehabilitation program, lasting 4 weeks prior to surgery, consists of three parts; physical state, nutritional state and mental health. In the case of physical condition, a series of supervised and "home-based" exercises (aerobic and functional) will be carried out in addition to specific pelvic floor exercises. The nutritional status will be evaluated by a nutritionist. Diet guidelines will be given and if there are deficiencies they will be supplemented. Regarding mental health, a visit will be made with a psychologist and group and online therapies will be offered. The outcomes will be evaluated before starting the prehabilitation program, at the end of it (just before surgery) and at 4, 8 and 16 weeks after surgery. The outcomes include variables on physical, nutritional and mental state, health-related quality of life (HRQoL), and continence and erectile function.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 100
- Patients with localized prostate cancer
- Candidates to robotic radical prostatectomy
- Non-localized prostate cancer
- Previous history of pelvic radiotherapy or pelvic surgery
- Failure to consent,
- Unwillingness to participate
- Anticipated failure to adhere to the program sessions.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Multimodal prehabilitation Multimodal prehabilitation This patients will receive the pre-hab program
- Primary Outcome Measures
Name Time Method Perioperative anxiety levels Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op) Change in perioperative anxiety levels
Hospital Anxiety \& Depression (HAD )
Scoring scale: 0-21 0-7 = Normal 8-10 = Borderline abnormal (borderline case) 11-21 = Abnormal (case)Continence recovery Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op) Change in continence during the prehabilitation program and postoperative recovery.
International Consultation on Incontinence Questionnaire (ICIQ)
Scoring scale: 0-21 Higher value means worse outcome
- Secondary Outcome Measures
Name Time Method Change in physical status by STS Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op) Sit-to-Stand (STS)
Time needed for 5 repeated chair rises. Higher time means worse physical status.Perceived application usability Week 4 Usability questionare
Includes a combination of the System Usability Scale (SUS) and the Net Promoter Score (NPS).
Scoring scale: 0-100 Higher value indicates better perceived usabilityChange in physical status by 6MWT Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op) 6 Minute Walk Test (6MWT)
Distance covered over a time of 6 minutes. Higher time means worse physical status.Erectile function recovery Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op) International Index Erectile Function (IIEF-5)
Change in erectile function during the prehabilitation program and postoperative recovery.
Scoring scale: 5-25 22-25: No erectile dysfunction 17-21: Mild erectile dysfunction 12-16: Mild to moderate erectile dysfunction 8-11: Moderate erectile dysfunction 5-7: Severe erectile dysfunctionChange in perceived general quality of life Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op) EORTC QLQ - C30
Scoring scale: 0-100 Higher value indicates higher perceived general quality of lifeEarly postoperative morbidity by CCI Week 8 (post-op) Comprehensive Complications Index (CII)
Scoring scale: 0-100 Higher value indicates more severe complicationChange in perception of physical status Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op) Yale physical activity survey (YPAS)
Part 1 - Scoring scale: 0-85680 kcal/week Part 2 - Scoring scale: 0-142 Part 3 - Scoring scale: 0.7-1.3
Higher values indicates higher activity.Change in perceived prostate quality of life Week 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op) EORTC QLQ - PR25
Scoring scale: 0-100 Higher value indicates higher perceived prostate quality of lifeEarly postoperative morbidity by CDC Week 8 (post-op) Clavien-Dindo Classification (CDC)
Scoring scale: 1-5 Higher value indicates more severe complicationNutritional status Week 0 and 4 Nutritionist final evaluation summarized as optimal or suboptimal by the specialist.
Satisfaction with the multimodal program Week 4 Satisfaction questionnaire
Scoring scale: 0-45 Higher value indicates higher satisfaction
Trial Locations
- Locations (1)
Hospital Clinic de Barcelona
🇪🇸Barcelona, Catalonia, Spain